The Neurologic Patient



The Neurologic Patient


Hypes Cameron

Natt Bhupinder



INTRODUCTION

Airway management is frequently necessary for patients with neurologic injury or disease. The principles of airway management in neurologic patients are fundamentally the same as in all other critically ill patients—obtain a secure conduit to facilitate gas exchange in as safe a manner as possible. Neurologic patients require intubation for a variety of reasons, most of which are like other critically ill patient populations. Broadly, these relate to airway protection (depressed level of consciousness, aspiration, or to facilitate imaging, procedures, and treatments) or correcting defective gas exchange (hypoxemia, hypercapnia).

There is a history of approaching the intubation of neurologic patients differently, often with complicated pharmacologic cocktails such as high-dose fentanyl and lidocaine prior to induction. While different approaches may be warranted for certain neurologic patients and will be discussed here, these are based on largely physiologic or mechanistic grounds rather than patient outcomes data. Evidence to support modification of the usual airway strategies for neurologic patients is limited and largely derived from theory or, at best, observational data. Such nuances and pretreatment regimens increase complexity and task loading. The fundamentals of safe airway management discussed throughout this book that apply to all patients also apply to neurologic patients and should be the priority to prevent complications.


THE CLINICAL CHALLENGE—PREVENTION OF SECONDARY BRAIN INJURY

The most important nuance with intubation in most neurologically injured patients relative to other types of critical illness is their susceptibility to secondary brain injury. The primary brain injury is the initial insult—such as an ischemic stroke, intraparenchymal hemorrhage, or brain trauma, and has typically already occurred. Secondary brain injury happens when physiologic conditions conspire to potentiate or cause ongoing brain injury. The most common physiologic conditions leading to secondary brain injury are hypoxemia, hypotension, and hypercapnia—all conditions directly related to and affected by airway management. These physiologic parameters have an outsized effect on brain tissue oxygen delivery because the injured brain suffers from impaired autoregulation. The mechanisms that typically control the delivery of blood and oxygen to tissues are unable to compensate for inadequate tissue delivery. Most data on secondary brain injury are derived from the ischemic stroke and traumatic brain injury (TBI) literature but are likely applicable to any neurologic insult in which cerebral autoregulation is impaired such as intracranial hemorrhage, subarachnoid hemorrhage, and conditions of elevated intracranial pressure (ICP).


Hypoxemia

The effects of even transient hypoxemia magnify brain injury in acutely neurologically injured patients and deserves special attention. Hypoxemia during acute ischemic stroke is thought to further damage the ischemic penumbra and is associated with increased risk of neurologic deterioration, institutionalization, and mortality.1,2 In patients with TBI, hypoxemia, even on a single measurement, is associated with increased mortality.3 Blood oxygen content requirements in acute neurologic patients are often higher with current guidelines from the American Heart Association recommending maintaining oxygen saturation >94% in patients with acute ischemic stroke4 and the American College of Surgeons recommending ≥95% in patients with TBI.5

Studies of strategies to prevent hypoxemia during intubation are mixed and will likely be a subject of debate and ongoing research for some time. We recommend the following practices
during RSI of patients with acute neurologic injury, especially those with ischemic stroke, intracranial hemorrhage, or TBI to prevent peri-intubation hypoxemia:



Hypotension

Cerebral blood flow (CBF) in patients without neurologic disease is maintained constant across a wide range of arterial blood pressure due to cerebral autoregulatory mechanisms that act to dilate or constrict the cerebral vasculature. In patients with neurologic injury, these autoregulatory mechanisms are disturbed. This results in CBF and therefore cerebral oxygen delivery becoming directly dependent on arterial blood pressure. This mechanism makes neurologic patients highly susceptible to secondary brain injury due to hypotension, with hypotension leading to hypoperfusion of injured but not yet destroyed areas of brain such as in the penumbra of ischemic stroke and in TBI. Early hypotension in both ischemic stroke and TBI have been associated with poor outcomes and in the case of TBI, the effects of concomitant hypotension and hypoxemia are supra-additive.3

While avoiding hypotension during intubation in all patients should be a goal, particular attention should be given to the neurologic patient. For ischemic stroke, the AHA recommends correcting hypotension but does not recommend a specific value. Systolic blood pressure (SBP) below 120 mm Hg has been associated with poorer outcomes in acute ischemic stroke, and in the absence of more specific data using this value or a mean arterial pressure (MAP) of 65 mm Hg seem reasonable targets.4 On the other hand, the Brain Trauma Foundation recommends an age-based goal for patients with TBI: SBP goal ≥100 mm Hg for patients 50 to 69 years old or ≥110 mm Hg for patients 15 to 49 or over 70 years old.10

Like hypotension, hypertension causes increased CBF and is associated with secondary brain injury in a number of neurologic conditions such as ischemic stroke, intracranial hemorrhage, subarachnoid hemorrhage, and TBI. Blood pressure targets for treating hypertension vary by the type of neurologic insult and are a matter of ongoing research and controversy. It is reasonable to consider the degree of hypertension in relation to the goal blood pressure when selecting the induction agent for RSI. It is advisable to avoid agents that may exacerbate the hypertension such as ketamine when suitable alternatives are available. Using an induction agent that is expected to lower the blood pressure (e.g., propofol) is more reasonable in the presence of severe hypertension but should be avoided if antihypertensive agents have already been started and the BP is approaching the goal
value to avoid overshooting. The hypotensive effect of the induction agent is unpredictable and transitory, making it not truly an antihypertensive therapy. We generally advocate using a hemodynamically neutral induction agent in conjunction with a short-acting antihypertensive infusion (e.g., nicardipine, clevidipine) to control hypertension.

There are largely two mechanisms by which airway management causes hypotension in the acute neurologic patient. The first is pharmacologic with agents used for induction and postintubation sedation causing hypotension directly and via reduced sympathetic outflow. The second is the transition from negative-pressure breathing to positive-pressure ventilation which results in an increase in intrathoracic pressure and concomitant decrease in cardiac preload, an effect which is potentiated in hypovolemia. Strategies to avoid peri-intubation hypotension include:



Hypercapnia

The partial pressure of arterial carbon dioxide (PaCO2) has a more pronounced effect on cerebral autoregulation and therefore CBF than any other metabolite. In fact, CBF varies widely even within the normal range of PaCO2 values. CBF is reduced when PaCO2 is low, placing patients at risk of cerebral ischemia. On the other hand, hypercapnia causes increased CBF which may result in hyperemia, cerebral edema, and elevated ICP. For these reasons, the objective for the PaCO2 in neurologic patients will be normocapnia (PaCO2 35 to 45) in nearly all cases.10,11 Widespread early use of hyperventilation in TBI patients is no longer recommended.10 There are two notable exceptions to this normocapnia rule: (1) A short duration of hyperventilation may be reasonable as a temporizing measure in patients with impending herniation or elevated ICP (e.g., until a surgical therapy can be performed) (2) In patients with baseline severe lung disease and chronic hypercapnia resulting in chronic renal compensation such that normalizing the PaCO2 would cause a significant metabolic alkalosis, a PaCO2 that normalizes the pH should be targeted.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Feb 1, 2026 | Posted by in CRITICAL CARE | Comments Off on The Neurologic Patient

Full access? Get Clinical Tree

Get Clinical Tree app for offline access